Human trials of a coronavirus (SARS-CoV-2) vaccine have begun

Preliminary human trials of a coronavirus (SARS-CoV-2) vaccine have begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The vaccine was injected into four volunteers as part of clinical trials funded by the US National Institutes of Health and, while results of this phase 1 trial are more than a year away, the eventual aim is to create an effective vaccine against the pandemic-causing virus. READ MORE…

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.